DK136904C - Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive 2-(heteroaryl-methyl)-5,9beta-dialkyl-6,7-benzomorphaner eller syreadditionssalte deraf - Google Patents

Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive 2-(heteroaryl-methyl)-5,9beta-dialkyl-6,7-benzomorphaner eller syreadditionssalte deraf

Info

Publication number
DK136904C
DK136904C DK336173A DK336173A DK136904C DK 136904 C DK136904 C DK 136904C DK 336173 A DK336173 A DK 336173A DK 336173 A DK336173 A DK 336173A DK 136904 C DK136904 C DK 136904C
Authority
DK
Denmark
Prior art keywords
benzomorphanes
9beta
racemic
dialkyl
heteroaryl
Prior art date
Application number
DK336173A
Other languages
Danish (da)
English (en)
Other versions
DK136904B (da
Inventor
H Merz
A Langbein
K Stockhaus
H Wick
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of DK136904B publication Critical patent/DK136904B/da
Application granted granted Critical
Publication of DK136904C publication Critical patent/DK136904C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK336173A 1972-06-19 1973-06-18 Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive 2-(heteroaryl-methyl)-5,9beta-dialkyl-6,7-benzomorphaner eller syreadditionssalte deraf DK136904C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2229695A DE2229695A1 (de) 1972-06-19 1972-06-19 2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
DK136904B DK136904B (da) 1977-12-12
DK136904C true DK136904C (da) 1978-06-26

Family

ID=5848060

Family Applications (1)

Application Number Title Priority Date Filing Date
DK336173A DK136904C (da) 1972-06-19 1973-06-18 Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive 2-(heteroaryl-methyl)-5,9beta-dialkyl-6,7-benzomorphaner eller syreadditionssalte deraf

Country Status (13)

Country Link
US (1) US3931194A (fr)
JP (1) JPS5711908B2 (fr)
AT (6) AT328627B (fr)
BE (1) BE801079A (fr)
CH (9) CH582697A5 (fr)
DE (1) DE2229695A1 (fr)
DK (1) DK136904C (fr)
ES (8) ES416037A1 (fr)
FR (1) FR2189056B1 (fr)
GB (1) GB1433817A (fr)
NL (1) NL7308483A (fr)
NO (1) NO137694C (fr)
SE (1) SE405121B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2437610A1 (de) * 1974-08-05 1976-02-26 Boehringer Sohn Ingelheim Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung
GB1575009A (en) * 1976-06-21 1980-09-17 Acf Chemiefarma Nv 6,7-benzomorphan derivatives
JPS63177704A (ja) * 1987-01-16 1988-07-21 松山株式会社 農作業機連結装置
EP2183228B1 (fr) 2007-07-26 2014-08-20 Vitae Pharmaceuticals, Inc. INHIBITEURS CYCLIQUES DE LA 11ß -HYDROXYSTÉROÏDE DÉSHYDROGÉNASE 1
WO2009063061A2 (fr) 2007-11-16 2009-05-22 Boehringer Ingelheim International Gmbh Dérivés aryl- et hétéroarylcarbonyles de benzomorphanes et structures liées à ceux-ci, médicaments contenant de tels composés et leur utilisation
CA2708303A1 (fr) 2007-12-11 2009-06-18 Vitae Pharmaceuticals, Inc. Inhibiteurs cycliques d'uree de la 11.beta.-hydroxysteroide dehydrogenase 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
CA2712500A1 (fr) 2008-01-24 2009-07-30 Vitae Pharmaceuticals, Inc. Carbazate cyclique et inhibiteurs du type semi-carbazide de la 11beta-hydroxysteroide deshydrogenase 1
JP5538239B2 (ja) * 2008-02-12 2014-07-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ベンゾモルファン及び関連骨格の尿素誘導体、そのような化合物を含む医薬ならびにそれらの使用
EP2254872A2 (fr) 2008-02-15 2010-12-01 Vitae Pharmaceuticals, Inc. Inhibiteurs de 11beta-hydroxystéroïde deshydrogénase 1
EP2291370B1 (fr) 2008-05-01 2013-11-27 Vitae Pharmaceuticals, Inc. Inhibiteurs cycliques de la 11-bêta-hydroxystéroïde déhydrogénase 1
CA2722427A1 (fr) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Inhibiteurs cycliques de la 11-beta-hydroxysteroide dehydrogenase 1
CA2723039A1 (fr) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Inhibiteurs cycliques de la 11-beta-hydroxysteroide dehydrogenase 1
TW200950780A (en) 2008-05-13 2009-12-16 Boehringer Ingelheim Int Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
WO2010010157A2 (fr) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Inhibiteurs de la 11 bêta-hydroxystéroïde déshydrogénase 1
AU2009274567B2 (en) 2008-07-25 2013-04-04 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
US8680093B2 (en) 2009-04-30 2014-03-25 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2011011123A1 (fr) 2009-06-11 2011-01-27 Vitae Pharmaceuticals, Inc. Inhibiteurs cycliques de la 11-bêta-hydroxystéroïde déshydrogénase 1 basée sur la structure 1,3-oxazinan-2-one
AR078887A1 (es) * 2009-11-06 2011-12-07 Boehringer Ingelheim Int Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina y composiciones farmaceuticas que los contienen.
US8933072B2 (en) 2010-06-16 2015-01-13 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
US8735585B2 (en) 2011-08-17 2014-05-27 Boehringer Ingelheim International Gmbh Indenopyridine derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE582575A (fr) * 1958-09-22
FR1281227A (fr) * 1958-09-22 1962-01-12 Smith Kline French Lab Perfectionnements apportés aux procédés pour la préparation de dérivés d'aralcoylbenzomorphane
CS166802B2 (fr) * 1971-02-08 1976-03-29 Boehringer Sohn Ingelheim
SE392895B (sv) * 1971-08-24 1977-04-25 Sumitomo Chemical Co Forfarande for framstellning av bensomorfanderivat och deras salter

Also Published As

Publication number Publication date
ATA490074A (de) 1975-06-15
NL7308483A (fr) 1973-12-21
ATA489874A (de) 1975-07-15
AT325218B (de) 1975-10-10
FR2189056B1 (fr) 1976-10-22
CH582698A5 (fr) 1976-12-15
GB1433817A (en) 1976-04-28
CH583228A5 (fr) 1976-12-31
JPS5711908B2 (fr) 1982-03-08
ES431511A1 (es) 1976-11-01
ES431512A1 (es) 1976-11-01
AT329200B (de) 1976-04-26
NO137694B (no) 1977-12-27
AT328627B (de) 1976-03-25
DE2229695A1 (de) 1974-01-31
ES431514A1 (es) 1976-11-01
CH583230A5 (fr) 1976-12-31
AT328629B (de) 1976-03-25
DK136904B (da) 1977-12-12
ATA489974A (de) 1975-07-15
JPS4961170A (fr) 1974-06-13
ES431516A1 (es) 1976-11-16
CH583231A5 (fr) 1976-12-31
CH589649A5 (fr) 1977-07-15
AT329199B (de) 1976-04-26
NO137694C (no) 1978-04-05
CH589648A5 (fr) 1977-07-15
AT328628B (de) 1976-03-25
ES431513A1 (es) 1976-11-01
ATA489774A (de) 1975-06-15
CH583229A5 (fr) 1976-12-31
ATA489474A (de) 1975-06-15
ES431515A1 (es) 1976-11-01
AU5704673A (en) 1974-12-19
FR2189056A1 (fr) 1974-01-25
CH583227A5 (fr) 1976-12-31
SE405121B (sv) 1978-11-20
CH582697A5 (fr) 1976-12-15
ES416037A1 (es) 1976-02-16
BE801079A (fr) 1973-12-18
US3931194A (en) 1976-01-06
ES431510A1 (es) 1976-11-01

Similar Documents

Publication Publication Date Title
DK136904C (da) Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive 2-(heteroaryl-methyl)-5,9beta-dialkyl-6,7-benzomorphaner eller syreadditionssalte deraf
DK131029B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-alkylaminopropaner eller syreadditionssalte deraf.
DK129447B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-sek.-alkylaminopropaner eller syreadditionssalte heraf.
DK142750C (da) Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive dopaminderivater eller syreadditionssalte deraf
DK138602B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive penicilliner eller salte deraf.
DK140281B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-cycloalkylaminopropaner eller syreadditionssalte heraf.
DK136527B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive p-alkoxyfenoxypropanolaminer eller syreadditionssalte deraf.
DK137990C (da) Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive 1-arylpropyl-(2)-piperazinderivater eller syreadditionssalte deraf
DK129127B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 2-(furylmethyl)-6,7-benzomorphaner eller deres syreadditionssalte.
DK124081B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive piperazinderivater eller syreadditionssalte deraf.
DK138491B (da) Analogifremgangsmåde til fremstilling af N-(1-cyclohexyl-3-pyrrolidinyl)-benzamider eller syreadditionssalte deraf.
DK125639B (da) Analogifremgangsmåde til fremstilling af racemisk eller optisk aktivt 1-(2-nitrilophenoxy)-2-hydroxy-3-ethylaminopropan eller syreadditionssalte heraf.
DK139582B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive benzocycloheptaisoquinolin-forbindelser eller syreadditionssalte deraf.
DK133980C (da) Analogifremgangsmade til fremstilling af racemiske eller optisk aktive diphenylalkyllactamimidderivater eller syreadditionssalte deraf
DK129235B (da) Fremgangsmåde til fremstilling af racemiske eller optisk aktive quinolinderivater eller syreadditionssalte deraf.
DK133555C (da) Analogifremgangsmade til fremstilling af racemiske eller optisk aktive n-thienylmethyl-heterocycliske forbindelser eller syreadditionssalte deraf
DK130958B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-hydroxyalkylaminopropaner eller fysiologisk tålelige syreadditionssalte heraf.
DK136823B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive derivater af imidazo(2,1-b)thiazol eller syreadditionssalte deraf.
DK132628C (da) Analogifremgangsmade til fremstilling af 1-(2-delta2-imidazolinyl)-2,2-diarylcyclopropaner eller syreadditionssalte deraf
DK129992B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 3,5-disubstituerede fenylætanolaminforbindelser eller terapeutisk acceptable syreadditionssalte deraf.
DK133004C (da) Analogifremgangsmade til fremstilling af racemiske eller optisk aktive benzomorphanderivater eller salte deraf
DK131470B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive thiazolino-pyrimidin-5-on derivater eller syreadditionssalte deraf.
DK135942C (da) Analogifremgangsmade til fremstilling af racemiske eller optisk aktive 1-(m-acyloxyphenyl)-1-hydroxy-2-n-alkylaminoethanereller syreadditionssalte deraf
DK135941C (da) Analogifremgangsmaade til fremstilling af 1-cyclopropyl-1-phenyl-3-amino-1-propanoler eller syreaddittionssalte deraf
DK122128B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 2-(4,4'-dihalo)-benzhydryl-3-quinuclidinoler eller syreadditionssalte deraf.